Fig. 2
From: Factors affecting long-term efficacy of T regulatory cell-based therapy in type 1 diabetes
Mixed meal tolerance test performed at the 24th month of follow-up. Levels of C-peptide in MMTT in T1DM children at the 24th month of follow-up are displayed separately for untreated controls (NO tregs), patients treated with single infusion of Tregs (single dose) and patients treated with two infusions of Tregs (two doses). The values are given as medians (min.–max.) and the legend shows the timing of C-peptide measurements in minutes during the test. The horizontal lines represent significant differences (p < 0.05) in C-peptide levels in Kruskal–Wallis ANOVA between the untreated group and the group treated with two doses of Tregs in all ten time points of the test